2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
6
Recurrence
3
Pancreatic Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Uterine Cervical Neoplasms
1
Tracheal Diseases
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Peritoneal Neoplasms
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Mucopolysaccharidosis I
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphedema
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Interventions
Capecitabine
20
Oxaliplatin
13
Irinotecan
8
spartalizumab
6
tislelizumab
4
Radiation
4
Neoadjuvant Therapy
4
Immune Checkpoint Inhibitors
4
Fluorouracil
4
toripalimab
3
sintilimab
2
camrelizumab
2
Radiotherapy
2
Leucovorin
2
Celecoxib
2
veliparib
1
peposertib
1
nimotuzumab
1
irinotecan sucrosofate
1
XELOX
1
Thymalfasin
1
Radiotherapy, Intensity-Modulated
1
Injections
1
HMPL-013
1
Folfox protocol
1
Diathermy
1
Combined Modality Therapy
1
Chemoradiotherapy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Cancer
×
Combined Modality Therapy
×
Clear all
NCT03034473
2023-12-28
TransValid-A
University Medical Center Goettingen
Phase NA
Unknown
200 enrolled